Precia^TM is our line of pre-clinical products geared toward researchers who wish to conduct in vivo pre-clinical imaging studies using a variety of targets in oncology, immunology, and inflammation.  Our pre-clinical products include reagents for use with microPET, microSPECT, and optical imaging platforms.   We also offer unconjugated and DOTA-conjugated fragments for customers who want to perform custom labeling with other radioisotopes or labels.

Our Precia^TM pre-clinical imaging agents address the need for a greater diversity of pre-clinical imaging tools for PET and SPECT small animal imaging.  The use of pre-clinical imaging has been broadly adopted by researchers in academia and industry alike.

MicroPET imaging using ¹²⁴I-PSMA minibody demonstrates specific targeting to xenografts expressing PSMA

Plug-in missing? Download Quicktime here.